RJA
CVET

Raymond James & Associates’s Covetrus, Inc. Common Stock CVET Stock Holding History

Raymond James & Associates’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-17,410
Closed -$361K – 4188
2022
Q2 		$361K Buy
+17,410
New +$310K ﹤0.01% 3113
2022
Q1 		– Sell
-42,994
Closed -$859K – 4334
2021
Q4 		$859K Sell
42,994
-15,510
-27% -$292K ﹤0.01% 2719
2021
Q3 		$1.06M Sell
58,504
-50,100
-46% -$1.15M ﹤0.01% 2547
2021
Q2 		$2.93M Buy
108,604
+1,484
+1% +$41.5K ﹤0.01% 1846
2021
Q1 		$3.21M Buy
107,120
+16,956
+19% +$578K ﹤0.01% 1714
2020
Q4 		$2.59M Buy
90,164
+15,860
+21% +$428K ﹤0.01% 1741
2020
Q3 		$1.81M Buy
74,304
+49,717
+202% +$1.07M ﹤0.01% 1815
2020
Q2 		$440K Buy
24,587
+595
+2% +$7.82K ﹤0.01% 2673
2020
Q1 		$195K Buy
23,992
+4,187
+21% +$47.8K ﹤0.01% 3050
2019
Q4 		$261K Sell
19,805
-46,158
-70% -$559K ﹤0.01% 3174
2019
Q3 		$784K Sell
65,963
-84,896
-56% -$1.57M ﹤0.01% 2339
2019
Q2 		$3.69M Buy
150,859
+57,232
+61% +$1.65M 0.01% 1413
2019
Q1 		$2.98M Buy
+93,627
New +$3.32M ﹤0.01% 1512

Other funds holding CVET

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Raymond James & Associates's CVET Position: Q3 2022 in Review

Raymond James & Associates sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2022, closing a stake of 17,410 shares — an estimated $361K sold.

Raymond James & Associates first reported a position in CVET in Q1 2019 and held it in 13 quarters. The position peaked at $3.69M in Q2 2019. 250 funds tracked by Wall St. Rank hold CVET as of Q3 2022.

  • Raymond James & Associates reported no remaining Covetrus, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Raymond James & Associates sold 17,410 Covetrus, Inc. Common Stock shares in Q3 2022, an estimated $361K.
  • Raymond James & Associates first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 13 quarters.
  • Raymond James & Associates's Covetrus, Inc. Common Stock position peaked at $3.69M in Q2 2019.
  • 250 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2022.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.